Health Bulletin 9/July/2022 Roshni Dhar9 July 2022 5:27 PM ISTHere are the Top Health stories for the day:Medical students taught gender politics with both sexes separated by curtain in classroomControversy...
Zydus Lifesciences unveils anti-diabetic drug molecule Sitagliptin in India Ruchika Sharma9 July 2022 12:00 PM ISTSitagliptin is the gold standard in the Dipeptidyl peptidase 4 inhibitor (DPP4i) category with over 62% market share in the global market.
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 3:28 PM ISTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin Susmita Roy27 Jun 2022 6:15 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
NPPA fixes price of 84 formulations, revises 1 Ruchika Sharma13 May 2022 3:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has...
NPPA fixes retail prices of Linagliptin, Sitagliptin FDCs, Details Ruchika Sharma11 May 2022 6:00 PM ISTNew Delhi: Through a recent notice, National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the fixed dose combinations (FDCs)...
Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna A Singhania15 April 2022 5:22 PM ISTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 7:02 PM ISTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
Drug makers to include DPP4 inhibitors induced Arthralgia in package insert, says CDSCO panel Medical Dialogues Team15 Jan 2022 5:35 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Unichem Labs diabetes drug Sitagliptin gets USFDA approval Ruchika Sharma11 July 2021 12:00 PM ISTSitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Sun Pharma gets CDSCO panel ok for BE study of Sitagliptin, Metformin, Glimepiride FDC Medical Dialogues Team24 Jun 2021 4:52 PM ISTNew Delhi: Pharmaceutical major, Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
